Get Connected:

Hepatitis C
The MD Magazine Hepatitis C condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Statins Slow Liver Disease in HIV/HCV Patients
Having HIV puts patients co-infected with hepatitis C at far higher risk. A Baltimore team looked at using statins to slow the course of the liver disease.
Study results show there are minimal drug-drug interactions between tenofovir alafenamide-based antiretroviral regimens for HIV and ledipasvir/sofosbuvir combination treatment for hepatitis C.
Comparing current treatment models to lessons learned in the early days of the AIDs epidemic, University of Southern California researchers are advocating that more than just the sickest patients with hepatitis C be treated with new drugs that have much higher cure rates than past regimens.
Young suburban heroin users who were admitted recently to a Princeton, NJ drug rehab facility showed an unexpectedly high incidence of hepatitis C infection.
Japanese regulators have approved AbbVie's Viekirax to treat patients with genotype 1 chronic hepatitis C, including those with compensated cirrhosis, the most common type of hepatitis in that country.
Gilead continues a string of recent successes with stellar data from four late-stage studies showing that a combination featuring its blockbuster polymerase inhibitor sofosbuvir (Sovaldi®) and the experimental NS5A inhibitor velpatasvir is effective across all hepatitis C virus (HCV) genotypes.
A common liver health measurement could be a strong indicator of risk of hepatosteatosis in patients with chronic hepatitis C virus (HCV) infection, a Taiwanese study in BMJ Open suggests.

Most Popular

$vacMongoViewPlus$ $vAR$